A clinical impression of a combination-type contraceptive: Neo-Lyndiol
Gede, C.E.
Journal of International Medical Research 3(4): 284-291
1975
ISSN/ISBN: 0300-0605 PMID: 1165003 DOI: 10.1177/030006057500300411Document Number: 506847
165 healthy women were treated during a total of 3281 cycles with Ne o-Lyndiol, 2.5 mg lynestrenol and .05 mg ethinyl estradiol. A treatment cycle consisted of 28 days, 6 of which are tablet free. The cycles were without pregnancies. The proportion of patients experiencing irregular bleeding and side effects was low, diminishing further with length of treatment. Duration of withdrawal bleeding showed a tendency to decrease. The dropout rate was 5.5% with an average of 20 completed cycles. Neo-Lyndiol was a reliable preparation, controlling the cycle well and causing few side effects.